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Abstract 
Introduction: The aim of this study was to analyze the diagnostic potential of contrast enhanced ultrasound (CEUS) for the reco-
gnition of focal lesions of the spleen and liver in patients suffering from sarcoidosis. 
Material and methods: We analyzed the outcome of diagnostic imaging in a group of 21 patients treated for pulmonary sarco-
idosis, searching for the systemic infiltration of the liver and/or spleen. All the participants are patients with inactive disease, 
who are monitored every 6 months at the Pulmonology Clinic. Apart from the check-up high-resolution computed tomography 
(HR-CT) — every 2 years, patients underwent an initial ultrasound examination (US) and if there was a suspicion of systemic 
infiltration, abdominal CT and/or magnetic resonance imaging (MRI) and CEUS were performed. 
Results: In 18 patients suffering from pulmonary sarcoidosis diagnostic imaging revealed no systemic infiltration. In three pa-
tients, the use of CEUS exposed the presence of lesions in the parenchymal organs. In all cases, the images from CEUS were 
consistent with those from CT/MRI. 
Conclusions: CEUS has the potential to become a reliable and safe screening tool for systemic infiltration in patients with sarco-
idosis. It may also be an important method of monitoring the effects of therapy. 
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Streszczenie
Wstęp: Celem pracy była analiza potencjału diagnostycznego ultrasonografii wzmocnionej kontrastem (CEUS) w wykrywaniu 
zmian ogniskowych w wątrobie i śledzionie u pacjentów cierpiących z powodu sarkoidozy.
Materiał i metody: Przeanalizowano wyniki badań obrazowych w grupie 21 pacjentów leczonych z powodu postaci 
płucnej sarkoidozy, poszukując cech zajęcia wątroby i śledziony. Wszyscy uczestnicy to pacjenci w stadium nieaktywnej 
choroby, którzy są monitorowani co 6 miesięcy w Klinice Pulmonologii i Alergologii. Oprócz wykonywanego co 2 lata 
HRCT (high-resolution computed tomography) pacjentów poddano wstępnemu badaniu ultrasonograficznemu brzucha 
i jeżeli istniało podejrzenie sarkoidozy systemowej, zlecano tomografię komputerową jamy brzusznej i/lub rezonans 
magnetyczny oraz CEUS. 
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Wyniki: U 18 pacjentów z postacią płucną sarkoidozy wyniki badań obrazowych nie wykazały zajęcia narządów miąższowych. 
U 3 pacjentów użycie CEUS pozwoliło na wykrycie zmian w wątrobie i śledzionie, co potwierdziły badania TK i/lub RM. 
Wnioski: CEUS ma potencjał, aby stać się bezpiecznym i niezawodnym narzędziem przesiewowym w poszukiwaniu zmian sys-
temowych u pacjentów z sarkoidozą. Może być również skuteczną metodą monitorowania efektów terapii.
Słowa kluczowe: sarkoidoza, sarkoidoza śledziony i wątroby, CEUS, ultrasonografia wzmocniona kontrastem
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Introduction
Sarcoidosis is a multisystemic granuloma-
tous disease of unknown etiology that predomi-
nantly affects the lungs and intrathoracic lymph 
nodes, rarely (about 10%) the infiltration of spleen 
and liver, can be observed. The early detection of 
organ lesions in course of sarcoidosis is crucial, 
as it changes the classification of the disease and 
treatment strategy, thus influencing the long-term 
results of therapy. Unfortunately, the infiltration 
of abdominal organs is usually asymptomatic — 
delaying diagnosis [1].
HRCT is currently the standard diagnostic 
tool for monitoring patients with pulmonary sar-
coidosis. In cases of organ involvement localized 
subdiaphragmatically, CT/MRI of the abdomen 
and different ultrasound techniques (presenta-
tion B, Color and Power Doppler US etc.) are 
performed. MRI is already well established in this 
algorithm as a safe, accurate and reliable method, 
but its wide use is limited. Therefore there is 
a need to find new, sufficiently sensitive and 
noninvasive methods to screen for systemic 
sarcoidosis. Contrast-enhanced ultrasonogra-
phy (CEUS) for that matter reduces the risk of 
complications associated with the use of iodine 
contrast and does not produce harmful radiation. 
Consequently, the implementation of contrast-en-
hanced ultrasound opens new perspectives for 
the detection of abdominal lesions in sarcoidosis.
The purpose of this study was to an-
alyze the diagnostic potential of CEUS for 
the recognition of focal lesions of the spleen and 
liver, in patients suffering from sarcoidosis. 
Material and methods
Study group consisted of 21 patients suffe-
ring from chronic pulmonary sarcoidosis. The 
subjects included 13 women and 8 men, with the 
mean age 38 years (range 28–47 years, SD 5.5). 
If there was a suspicion of systemic infiltration 
(elevated liver enzymes, fever, abdominal pain, 
lymphadenopathy, liver/spleen enlargement or 
heterogeneity on initial US) patient was referred 
to the Radiology Department, where the following 
diagnostic pathway was introduced:
1.  Standard US examination (B presentation, 
US-Color Doppler, US-Power Doppler).
2.  Abdominal CT and/or MRI (CT only — 10; 
MRI only — 8; CT and MRI — 3).
3.  CEUS.
Patients were monitored at the Pulmonology 
Department every 6 months, where these proce-
dures were performed on an outpatient basis. If 
the diagnostic imaging outcome was positive the 
patient was subjected to a biopsy (only in case 
of liver lesions). The risks, benefits, and possible 
complications were explained to the patient prior 
to the procedures. Informed consent was obtained 
before commencement of data collection. 
Dynamic MRI was conducted using Sie-
mens-Avanto scanner (Siemens, Erlangen, 
Germany) with the contrast protocol – Pro-
Hance (Bracco Int. Milan, Italy). CT scan was 
performed using GE-Light-Speed 64 scanner 
(GE Healthcare, Buc, France) with 4-phase contrast 
protocol — Iomeron 400 (Bracco Int. Milan, 
Italy). Ultrasound examination was performed 
using GE Vivid 7 (GE Healthcare, Buc, France) 
system with a convex transducer (type 3.5C). 
The study protocol included B-mode presenta-
tion and contrast-enhanced ultrasound. Acqui-
sition using B-mode presentation included the 
morphological assessment of the spleen and 
liver - we used the factory settings dedicated to 
the assessment of parenchymal organs. CEUS 
with SonoVue Diagnostics (Bracco Int. Milan, 
Italy) at a dose of 2.4 ml/study, administered 
by intravenous bolus was the last part of the 
acquisition. This was performed using a pro-
tocol with a low mechanical index (MI 0.1) 
and the default settings dedicated to contrast 
studies. Data from each study was recorded in a 
digital form and saved as several time loops to 
allow analysis on an external EchoPack PACS 
workstation (GE Healthcare, Buc, France). By 
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strengthening the intensity curves (TIC), local 
perfusion was evaluated in defined areas (ROI). 
All the biopsies were conducted under the ultra-
sound guidance, using a standard biopsy kit. 
This enabled precise planning and control in 
real time during the procedure. The equipment, 
which we used, was manufactured by Bard 
Magnum (Bard Biopsy Systems, Tempe, USA). 
The biopsy needle diameter was 16G. In each 
case 15mm long tissue samples were collected. 
The study protocol assumed, that the maxi-
mum diagnostic pathway will be no longer than 
7 days. The analysis of US, CT, MRI and CEUS 
data, was performed independently. The same, 
experienced ultrasonographers, who were una-
ware of patient’s clinical background, performed 
all ultrasound examinations. 
Results
In 18 patients suffering from pulmona-
ry sarcoidosis diagnostic imaging revealed 
no systemic infiltration. In 3 patients, the 
use of  CEUS and CT or/and MRI expo -
sed the presence of lesions in the parenchy-
mal organs: in case 1 — numerous lesions 
of the spleen (Figs 1, 2), in case 2 and 3 — few 
lesions of the liver (Figs 3, 4). In all 21 cases, the 
images from CEUS and CT/MRI were consistent. 
The cytological results for the patients with liver 
infiltration (case 2 and 3) who underwent core 
needle biopsy revealed the presence of non-case-
ating granulomas, which confirmed the diagnosis 
of systemic sarcoidosis. Biopsy was not performed 
in case 1 (spleen lesions) due to a high risk of 
bleeding. Data are summarized in Table 1.
Discussion
Early detection of lesions in patients suf-
fering from sarcoidosis affects the treatment 
strategy and improves prognosis. Respiratory 
involvement frequently presents as cough and 
dyspnoea whereas liver and spleen infiltration 
may be asymptomatic. Manifestations such as 
abdominal pain, portal hypertension, pancy-
topenia, spleen capsule rupture are observed 
in only 2–5% cases of hepatosplenic sarcoidosis [2].
On CT and MRI, small nodules in the li-
ver and spleen are often invisible – this is the 
reason why despite the development of ima-
ging techniques, a liver biopsy is still the dia-
gnostic gold standard. In cases of a seemin-
gly normal liver image on CT and MRI, 
a biopsy revealed the presence of nodules in 
Figure 1. Case 1. 41 year old woman, CEUS images. After adminis-
tration of contrast the numerous, small, well-limited nodules in the 
spleen are visible
Figure 2. Case 1. 41 year old woman, MRI images. After adminis-
tration of contrast the numerous, small, well-limited nodules in the 
spleen are visible
40–70% of cases [3, 4]. Similar dissonance can 
be observed at autopsy, where the extra-pul-
monary form is recognized more often than 
is diagnosed based on the current routinely 
used, imaging methods. The biopsy is still re-
garded as the reference method for the dia-
gnostic imaging. For the liver this procedure 
is considered to be safe, with occasional com-
plications. This is different when it comes to 
a biopsy of the spleen, which is a procedure 
burdened with considerable risk of bleeding 
and therefore not recommended. Spleen sarco-
idosis, although not uncommon, is also difficult 
to confirm solely in diagnostic imaging [5].
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Table 1. Results
N° Sex/
Age
Clinical data Methods Outcome
1 ♀/41 Sarcoidosis for 10 years,  
initial US (B-mode) — normal liver image; 
enlarged, heterogenous spleen, no focal 
lesions
MRI Enlarged spleen with numerous, small, low-signal nodules, diam. 
10–12 mm. Liver was homogenous and not enlarged (Fig. 2)
CEUS Numerous hypoechoic lesions in the spleen, diam. 10 mm (Fig. 1). 
Liver was homogenous and not enlarged
2 ♂/46 Sarcoidosis for 12 years, initial US  
(B-mode) — normal spleen image; enlar-
ged liver, no focal lesions. Liver infiltration 
was suspected on the basis of check-up 
HRCT 
CT Enlarged liver with 5 hypodense nodules diam. 5–18 mm in the 
right liver lobe, unenhanced after contrast administration (Fig. 4). 
Spleen was homogenous and not enlarged
CEUS Liver — 4 hypoechoic nodules diam. 7–19 mm in the right lobe 
(Fig. 3). Spleen was homogenous and not enlarged
BA  Presence of non-caseating granulomas
3 ♀/28 Sarcoidosis for 3 years, initial US 
(B-mode) — normal spleen image; en-
larged and heterogeneous with increased 
echogenicity liver without focal lesions 
CT Enlarged liver with numerous hypodense, unenhancing lesions 
diam. 7–18 mm within both liver lobes. Normal spleen image
CEUS Numerous hypoechoic lesions in the liver diam.  
8–17 mm within both liver lobes. Normal spleen image
BA Presensce of non cas-eating granulomas
4-21 ♀♂/28–
–47
Sarcoidosis for 0–10 years. Initial US  
(B-mode) — in 11 cases, increased  
and/or heterogeneous liver, last 7 cases 
normal image of the spleen and liver
CEUS Normal image of the spleen and liver
RM Homogeneous image of the spleen and liver
CT Homogeneous image of the spleen and liver
MRI — magnetic resonance imaging, CT — computed tomography, CEUS — contrast-enhanced ultrasound, BA — biopsy
Figure 3. Case 2 — 46 year old man. CE-US images. After admini-
stration of contrast the two small, well demarcated nodules in the 
segment VIII are visible
Figure 4. Case 2 — 46 year old man. CT images after administration of 
contrast. On the left side — the arterial phase, on the right side — the 
venous phase. The two small, well demarcated nodules in the segment 
VIII are visible in both phases
Due to the invasive nature of the biopsy and 
the risk of significant complications, we are 
looking for different diagnostic tools that are 
less invasive and have fewer contraindications. 
CT and MRI are good diagnostic methods, 
but in some cases they are contraindicated 
(CT — contrast allergy, MRI — claustrophobia, 
pacemakers, metallic foreign bodies). The use 
of a contrast agent to visualize focal lesions in 
parenchymal organs is an imaging diagnostic 
standard in CT and MRI [6]. The administration 
of a contrast agent is burdened with, sometimes 
severe complications related to the contrast 
medium, which eliminates them from diagno-
stic screening and limits their use in systemic 
sarcoidosis monitoring. The great advantage 
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of contrast media used in ultrasonography, 
is their safety, which has been confirmed by 
clinical trials [7]. Moreover, in the diagnosis 
of sarcoidosis it is important to eliminate the 
nephrotoxicity of the administered contrast.
Hepatosplenomegaly and lymphadenopa-
thy are the most common discoveries on CT 
and MRI scans, whereas granulomas are rare 
(about 5% of cases) [8, 9]. They show up most 
often in the form of multiple, well demarca-
ted, and non-enhancing (after contrast ad-
ministration) nodules with a diameter of up 
to 0.8 mm [10, 11]. This allowed us to reach 
a conclusion, that sarcoid nodules in the li-
ver and spleen, as non-vascularized structu-
res, which do not impair surrounding vascular 
architecture [12], will be visualized in CEUS 
as a hypoechoic nodules — which was con-
firmed in this study. The CEUS allowed 
us to distinguish healthy (hyperechoic) liver 
and spleen parenchyma from numerous, small, 
avascular (hypoechoic) granulomas.
In the literature, there are first attempts 
to use CEUS in the diagnosis of systemic sar-
coidosis. For example, a case of a 74-year-old 
woman, suffering from sarcoidosis, in which 
CEUS confirmed the presence of non-enhan-
cing nodules in the parenchymal organs [13]. 
Another one is a case of 38-year-old wo-
man with atypical pain in the left lower 
hemi-abdomen, in which CEUS revealed the 
presence of hypoechoic nodules in the liver [14]. 
The authors of those papers, observed a similar 
pattern of post-contrast behavior, as in our study. 
CEUS in a clear and transparent way 
shows the vascular structure of focal lesions 
on the background of a homogeneously enhan-
cing liver parenchyma, which allows the diffe-
rentiation between them, with efficacy similar 
to MRI [15]. In the literature, the nature of 
post-contrast enhancement is widely raised as a 
feature differentiating focal lesions of the liver 
in CEUS. Focal liver lesions vary in the degree 
of enhancement, contrast saturation time and 
the phenomenon called “washout”. There are no 
(in this diagnostic algorithm) hypoechoic, solid, 
well-demarcated, non-enhancing focal lesions, 
and such a pattern of behavior is represented 
by sarcoid nodules. This feature creates the 
prospect of high sensitivity and specificity of 
CEUS in granuloma diagnostics. 
Based on our observations, it seems that the 
main way of CEUS implementation could be sear-
ching for systemic sarcoidosis in patients already 
diagnosed with pulmonary sarcoidosis (based on 
biopsy, HRCT, biochemical and serological tests). 
This method has the potential to become a reliable 
screening tool in these patients (replacing more 
expensive and less available imaging methods — 
MRI, CT). It also seems that CEUS could be an 
important method of monitoring the effects of 
therapy in those patients, who require treatment. 
CEUS has all the qualities to play an important 
role in the examination of lesions occurring in 
systemic sarcoidosis.
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